Literature DB >> 9792553

Identification of Dep-1, a new gene regulated by the transcription factor Pax-3, as a marker for altered embryonic gene expression during diabetic pregnancy.

J Cai1, S A Phelan, A L Hill, M R Loeken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792553     DOI: 10.2337/diabetes.47.11.1803

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  6 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest.

Authors:  Sarah C Morgan; Hyung-Yul Lee; Frédéric Relaix; Lisa L Sandell; John M Levorse; Mary R Loeken
Journal:  Mech Dev       Date:  2008-07-13       Impact factor: 1.882

Review 3.  Hyperglycemia: its imminent effects on mammalian nephrogenesis.

Authors:  Yashpal S Kanwar; Baibaswata Nayak; Sun Lin; Shigeru Akagi; Ping Xie; Jun Wada; Sumant S Chugh; Farhad R Danesh
Journal:  Pediatr Nephrol       Date:  2005-05-05       Impact factor: 3.714

4.  Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy.

Authors:  R Li; B Thorens; M R Loeken
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

Review 5.  Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes.

Authors:  Mary R Loeken
Journal:  Curr Diab Rep       Date:  2020-09-12       Impact factor: 4.810

6.  Pax3 stimulates p53 ubiquitination and degradation independent of transcription.

Authors:  Xiao Dan Wang; Sarah C Morgan; Mary R Loeken
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.